GSK plc
GLAXF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $70.1M in total; no superinvestor holds it.
Other share classesGSK
Q2 2023 vs. Q1 2023
How the institutions holding GSK plc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 1 | 2 | +1 |
| Shares | 3.06M | 3.47M | +412.9K (+13.5%) |
| Value | $53.9M | $61.2M | +$7.32M (+13.6%) |
New holders (1)
Institutions that held GSK plc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 77,373 | $1.37M | 0.03% |
Sold out (0)
Institutions that held GSK plc at the end of Q1 2023 and filed for Q2 2023 without it.
None.